Introduction
Since the early description of HIV, the neurocognitive manifestations of infection have been recognized. HIV-associated neurocognitive disorders (HAND) were originally described in the 1980s as subacute encephalitis [1] . The term AIDS dementia complex (ADC) originated in 1986 after clinical and neuropathologic characterization of 46 AIDS patients with impaired mentation [2, 3] . The authors observed a triad of cognitive, motor, and behavioral symptoms in nearly 25% of HIV-infected subjects, with many eventually developing dementia. On autopsy, subcortical changes were seen with characteristic white matter pallor and rarefaction accompanied by lymphocytic and macrophage infi ltration [4] .
In response to these observations, the American Academy of Neurology AIDS Task Force in 1991 published criteria for HAND within the central nervous system (CNS) [5] . Two major categories were created: 1) a more severe form called HIV-associated dementia (HAD; previously known as ADC) and 2) a less impaired form called HIV-associated minor cognitive/motor disorder (MCMD). For both disorders, diagnosis required that symptoms impair everyday functioning. These criteria were validated through longitudinal studies that showed subjects with HAD had shorter life span [6, 7] .
Prior to the introduction of antiretroviral medications, a balance existed for patients with HAD between a high incidence and mortality due to AIDS-related complications [8] . The advent and widespread initial use of monotherapy (single agents such as zidovudine) and subsequently combination antiretroviral therapy (cART) reduced the incidence of HAD [9] . However, the prevalence of milder HAND has increased because individuals live longer with the disease and incompletely recover [10, 11] . The course of these less severe cases of HAND appears variable with stability, fl uctuations, progression, or sometimes regression [12] . cART has dramatically reduced the impact of opportunistic infections. Instead, substance abuse, hepatitis coinfection, neuropsychiatric comorbidities, and neurotoxic effects of cART have become the focus of differential diagnoses.
To account for these changes, the diagnostic criteria for HAND were recently revised. Criteria for HAD and MCMD were based primarily on severity of impairment on neuropsychological (NP) testing and on degree of functional impairment on activities of daily living with differentiation occurring according to the severity in these domains. Milder forms of HAND have prevailed since the advent of cART. HAND has now been divided into three conditions: asymptomatic neurocognitive impairment (ANI), HIV-associated mild neurocognitive disorder (MND), and HIV-associated dementia (HAD) [13••] . Individuals with ANI have demonstrable (and usually mild) cognitive impairment demonstrated by formal NP testing without any observed abnormalities in everyday functioning. The diagnosis of MND is similar to that for MCMD but requires not only mild to moderate NP testing abnormalities but also impairment in activities in daily living. Subjects with HAD have moderate to severe NP testing impairments and marked diffi culty in performing activating of daily living. Exclusion of delirium or comorbid conditions that might explain the dysfunction is required for these diagnoses.
Neuropathogenesis
HIV typically reaches the brain soon after initial infection, possibly shortly after seroconversion [14] . Clinical evaluation of subjects at the time of their HIV seroconversion noted the presence of meningitis or meningoencephalitis. In some of these cases, HIV p24 antigen was isolated from the cerebrospinal fl uid (CSF) near the time of seroconversion [15] .
One theory proposed for possible viral entrance involves infected monocytes traffi cking across the bloodbrain barrier (BBB): a "Trojan horse" mechanism. After these infected monocytes have crossed the endothelium, they settle as infected perivascular macrophages. It has been suggested that macrophages spread virus by cellto-cell contact with microglia cells [16] . Another theory for viral entry could be cellfree virus directly crossing the BBB or entering through the CSF. The presence of productive virus in endothelial and choroids plexus cells supports these theories [17] . Overall, macrophages in the perivascular spaces and multinucleated giant cells (fused macrophages and microglia cells) are the major brain cell types that support viral replication in the brain. Productive infection of neuroectodermal-derived cells (neurons, astrocytes, and oligodendrocytes) remains rare [18] .
Two views have been postulated concerning the dynamics of HIV entering the CNS [19] . One plausible view is that the CNS is exposed to repeated transitory contacts of virus transported across the BBB via monocytes. A dynamic viral equilibrium exists between the CNS and other loci of infection within the body. Activated infl ammatory cells freely enter and leave the brain and are likely traffi cking during the long duration of systemic HIV infection. A different viewpoint holds that the CNS could also serve as a relatively autonomous reservoir producing virus locally, with the opportunity for independent evolution under different immunologic and pharmacologic conditions than exist outside the CNS [20] . Most likely, both of these situations exist with one subtype dominating the other during different stages of the infection.
In both scenarios, viral replication surely occurs often in the CNS. With repeated exposures and enhanced viral replication within microglia, a complex cascade is instigated within the brain. Viral proteins are released within brain tissue. Microglia and astrocytes are stimulated by these proteins to produce chemokines, cytokines, and other infl ammatory mediators (ie, tumor necrosis factor-α, nitric oxide, neopterin, β 2 -microglobulin, and quinolinic acid) that regulate cell interactions for normal functioning [21] [22] [23] . These cell-encoded signals promote increased HIV replication in microglia cells and stimulate the further release of viral proteins. This may have a toxic effect on neurons, leading initially to neuronal dysfunction and eventually to neuronal loss.
Neuropathological evaluation of brain tissue of HIVinfected individuals is typically characterized by relatively nonspecifi c features such as white matter pallor, microglial nodules, and gliosis [12] . Multinucleated giant cells are more distinctive for advanced disease and are rarely seen the era of cART. However, when a constellation of these features are present in the setting of known HIV infection, a characteristic neuropathological signature is observed. Pathological changes are typically mild, even in HAD, with abnormalities most prominently occurring in central white matter, frontal cortices, basal ganglia, thalamus, and brain stem [24] . Cognitive status generally does not correlate with neuronal loss but instead with degree of damage to dendrites and synapses [25] . The overall scarcity of infected cells and the imprecise correlation between the severity of pathology and the degree of dementia suggest that multiple factors most likely play a role in neuropathogenesis [26] .
Diagnosis

Clinical features and course
HAND is characterized by a triad of cognitive, behavioral, and motor dysfunction. During the early stages, the general neurologic examination is often normal, with patients noting mild diffi culties in concentration, attention, and memory [27] . Patients may experience reading diffi culties with problems stemming from loss of concentration (thus requiring rereading) rather than comprehension. Affected individuals may be easily distracted, lose their train of thought, and require repeated reminders. Symptoms may intrude on activities of daily living such that common tasks take longer and become more laborious. Motor symptoms are typically mild and consist of slowed repetitive movements, clumsiness, unsteady gait, or balance problems.
Due to cART, more severe forms of HAND, such as HAD, are rare. In these more severe cases, cognitive and motor dysfunction are often quite distinct. Activities of daily living often cannot be adequately completed without assistance. Speech output is delayed, with long pauses when the patient is answering questions. Thought and emotional content are often impoverished, with behavioral changes causing a loss of spontaneity and initiative. Abulia and social withdrawal may be so striking that patients are mistakenly diagnosed with severe depression [28] . Motor abnormalities are usually prominent due to unsteady gait balance. The neurologic examination often shows frontal release signs, spasticity, and brisk deep tendon refl exes.
